SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

The iShares Silver Trust (SLV) is experiencing heightened volatility as investors debate the impact of macroeconomic pressures, including rising bond yields and U.S. dollar strength, against a long-term bullish thesis driven by industrial demand and inflation hedging. Community sentiment remains deeply polarized between 'stackers' who view price dips as generational buying opportunities for a looming supply deficit and those concerned that the current setup signals a deeper technical breakdown.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is experiencing intense volatility driven by conflicting geopolitical news and anticipation ahead of critical economic data releases. Community sentiment is deeply polarized, with traders actively debating whether the aggressive intraday price swings represent a sustainable V-shaped recovery or a manipulative bull trap designed to flush out retail positions.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is capturing investor attention following positive Phase 1 data for its subcutaneous Briumvi treatment in Myasthenia Gravis, which the community sees as a significant expansion of the drug's addressable market. Market participants are actively discussing the potential for a major buyout, with long-term investors pointing to strong commercial execution and upcoming clinical milestones as catalysts for a re-rating of the stock.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is experiencing a surge in trading activity driven by a strategic partnership with Aurelia Technologies to advance additive manufacturing for next-gen gas turbines, coupled with bullish sentiment surrounding its critical role as a supplier for the SpaceX ecosystem. Community members are actively discussing the stock's recovery potential, with many highlighting the company's Q1 growth, debt reduction, and strategic positioning in the aerospace and defense sectors as key catalysts for sustained long-term value.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is seeing significant investor attention as shares trade near five-year highs following a critical patent extension for its flagship drug Miplyffa through 2041. The community is actively discussing this development alongside multiple analyst price target upgrades, fueling speculation about long-term growth and the potential for a strategic acquisition.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing high volatility as investors weigh aggressive AI infrastructure spending and data center expansion against concerns regarding the company's debt levels. While community sentiment remains split between bullish expectations for blowout earnings and anxiety over broader sector weakness, many are focused on the stock's potential for a significant reaction following its upcoming earnings report.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing extreme intraday volatility driven by geopolitical tensions, profit-taking ahead of key economic data, and institutional rebalancing, leading to widespread debate among traders about whether the current price action signals a deeper correction or a classic 'buy-the-dip' opportunity. Investors are actively watching critical support levels as they navigate a landscape characterized by high-frequency swings and heavy options activity.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently a focal point for investors debating its status as a deeply undervalued fintech leader versus a long-term value trap, as the community intensely scrutinizes the company's aggressive share buyback strategy and potential for AI-driven margin expansion. While significant buyout rumors and strategic partnerships continue to drive speculative interest, sentiment remains sharply divided between those accumulating shares at historic lows and frustrated shareholders demanding more decisive leadership to overcome sustained price stagnation.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

Investors are actively debating the sustainability of the current market rally as broad indices like VOO hit all-time highs amid ongoing geopolitical tensions and uncertainty regarding interest rate policies. The community is heavily focused on balancing long-term index compounding against speculative rotations into AI-linked sectors, with many highlighting the importance of consistency over timing market pullbacks.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Donald Trumps recent attendance at an NBA game has sparked significant community backlash, with critics highlighting the irony of his presence amid ongoing geopolitical tensions and domestic policy failures. Meanwhile, investors remain skeptical of the stock's performance as participants actively trade insults over the company's valuation, recent market volatility, and the administration's controversial handling of international conflicts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced financial results and business highlights for the three months ended March 31, 2026. Highlights...

Sensus Healthcare (SRTS) Projected to Post Earnings on Thursday

Sensus Healthcare (NASDAQ:SRTS) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...

Sensus Healthcare (NASDAQ:SRTS) Shares Pass Below 50-Day Moving Average   - Here's Why

Sensus Healthcare (NASDAQ:SRTS) Stock Passes Below Fifty Day Moving Average - Time to Sell...

Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced...

Sensus Healthcare, Inc. (NASDAQ:SRTS) Receives Average Rating of "Moderate Buy" from Analysts

Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six ratings firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned...

Sensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest Update

Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) saw a large decrease in short interest in March. As of March 13th, there was short interest totaling 394,950 shares, a decrease of 18.3% from the February 26th total of 483,655 shares. Currently, 2.6% of the company's shares are sold short...

Sensus Healthcare, Inc. (NASDAQ:SRTS) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) have been given an average rating of "Moderate Buy" by the six analysts that are currently covering the firm, MarketBeat.com reports...

Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced the filing of a lawsuit in the Circuit Court for the Fifteenth...

Sensus Healthcare (NASDAQ:SRTS) Now Covered by Analysts at Alliance Global Partners

Alliance Global Partners started coverage on Sensus Healthcare in a research report on Friday. They set a "buy" rating and a $7.50 price target for the company...

Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100 Installed Base

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...

Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.

Current Price	$2.72
Prev Close	$2.69
Open	$2.77
Dividend Yield	0.00%
50-Day Moving Average	$3.73
Beta	0.84
Avg. Volume	93,678.04
PE Ratio	-5.67

52-Week High	$5.92
52-Week Low	$2.66
Market Capitalization	$44.28M
EPS (Annual)	-$0.4728
Price to Book	0.97
Revenue Per Employee	$458,033.33

SRTSSensus Healthcare Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SRTS News